|
2010
|
Invention
|
Compounds as pde iv and tnf inhibitors. This invention is directed to a [di(ether or thioether)he... |
|
2008
|
Invention
|
Mechanical doses counter for a powder inhaler. A rotatably actuated counter is disclosed. The cou... |
|
2007
|
Invention
|
Slave wheel counter mechanism useable with an inhaler. A counter mechanism useable with a dry pow... |
|
|
Invention
|
Compounds as pde iv and tnf inhibitors. A compound of formula XIX
3 as defined in the specificat... |
|
2006
|
Invention
|
Mechanical doses counter for a powder inhaler. A rotatably actuated counter (26) is disclos... |
|
|
Invention
|
Mechanical doses counter for a powder inhaler. A rotatably actuated counter (26) is disclosed. Th... |
|
|
Invention
|
Inhaler device and method of administering a medicament. An inhaler device (1) contains, or is ca... |
|
|
Invention
|
Improvements in or relating to inhalers. Abstract An inhaler device (1) contains, or is capable o... |
|
|
Invention
|
Method and packaging for pressurized containers.
A method for maintaining the enclosed volume of... |
|
2005
|
Invention
|
Compounds as pde iv and tnf-inhibitors.
This invention is directed to a [di(ether or thioether)h... |
|
|
Invention
|
Milling process for the production of finely milled medicinal substances.
The present invention ... |
|
|
Invention
|
Process for producing fine medicinal substance.
A method of producing fine medicament particles ... |
|
|
Invention
|
Inhaler |
|
2004
|
Invention
|
Substituted azabicyclic compounds. This invention is directed to physiologically active compounds... |
|
|
Invention
|
Dry powder for inhalation comprising a formoterol salt and ciclesonide. Provided herein is a stab... |
|
|
Invention
|
Stabilized pharmaceutical product. Use of an adsorbent and a sealed package (e.g. an overwrap) to... |
|
|
Invention
|
Adsorbents and uses thereof. Use of an adsorbent in preventing the formation of an adduct in a ph... |
|
|
Invention
|
Azaindoles. Chemical compositions containing physiologically active compounds of general formula ... |
|
|
Invention
|
Compounds as pde iv and tnf-inhibitors. This invention is directed to a [di(ether or thioether)he... |
|
|
Invention
|
Pressurized aerosol dispenser. A pressurized aerosol dispenser comprising a container (2) for mat... |
|
2003
|
Invention
|
Substituted tetrahydroisoquinolines. The invention is directed to physiologically active compound... |
|
|
Invention
|
Inhaler. A dry powder inhaler (10) for administering a dose of a medicament comprises a res... |
|
|
Invention
|
Inhaler. A dry powder inhaler (10) for administering a dose of a medicament comprises a reservoir... |
|
|
Invention
|
Method and packaging for pressurized containers. A method for maintaining the enclosed volume of ... |
|
|
Invention
|
Method and packaging for pressurized containers. A method for maintaining the enclosed volu... |
|
|
Invention
|
Imidazolyl-cyclic acetals.
which are useful as Tumor necrosis factor (TNF) inhibitors in treatin... |
|
|
Invention
|
Substituted alkanoic acids. The invention is directed to physiologically active compounds of gene... |
|
2002
|
Invention
|
Pharmaceutical product with an adsorbent. Use of an adsorbent in preventing the formation of an a... |
|
|
Invention
|
Pharmaceutical product with an adsorbent. Use of an adsorbent in preventing the formation o... |
|
|
Invention
|
Indane derivatives. The invention is directed to physiologically active compounds of general form... |
|
|
Invention
|
Pressurised aerosol dispenser. A pressurised aerosol dispenser comprising a container (2) f... |
|
|
Invention
|
Pressurised aerosol dispenser. A pressurised aerosol dispenser comprising a container (2) for mat... |
|
|
Invention
|
Azaindoles. The invention is directed to compositions containing physiologically active compounds... |
|
|
Invention
|
Azaindoles. The invention is directed to physiologically active compounds of general formul... |
|
|
Invention
|
Azaindoles. The invention is directed to physiologically active compounds of general formula (I):... |
|
|
Invention
|
Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases. The ... |
|
|
Invention
|
Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases. The invent... |
|
2001
|
Invention
|
Substituted bicyclic compounds. The invention is directed to physiologically active compounds of ... |
|
|
Invention
|
Aza-bicycles which modulate the inhibition of cell adhesion.
The invention is directed to physi... |
|
|
Invention
|
Substituted bicyclic heteroaryl compounds and their use as integrin antagonists. The invention is... |
|
|
Invention
|
Substituted benzoxazole compounds. The invention is directed to physiologically active compounds ... |
|
|
Invention
|
Heteroaryl-cyclic acetals. Compounds of formula (I) are described in which Het is a five or six m... |
|
2000
|
Invention
|
Dihydro-benzo(1,4)oxazines. The invention is directed to physiologically active compounds of form... |
|
|
Invention
|
Substituted anilides. The invention is directed to physiologically active compounds of formula (I... |
|
|
Invention
|
Inhalation device. An inhalation device which contains powdered medicament in the form of a medic... |
|
1999
|
Invention
|
Imidazolyl-cyclic acetals. Compounds of formula (I) are described in which R1 is optionally subst... |
